Tiffany Liu, DPM
Primary Podiatric Medicine · Dublin, OHNPI 1356743447
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by CDC Medical LLC at 35.6% of the total. Reporting peaked in 2022 at $1,549 and has fallen 96.9% since, to $48 in 2025.
Across 29 payments — averaging $116.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CDC Medical LLC$1K
- Smith+Nephew$643
- Paragon 28, Inc.$584
- Kerecis Limited$497
- DJO, LLC$112
- Trimed, Inc.$106
- plus $230 from 6 others
What the payments were for
- Travel & lodging$56917%
- Food & beverage$1,60248%
- Education$1,20036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CDC Medical LLC | 1 | $1,200 |
| Smith+Nephew | 14 | $643 |
| Paragon 28, Inc. | 2 | $584 |
| Kerecis Limited | 3 | $497 |
| DJO, LLC | 1 | $112 |
| Trimed, Inc. | 1 | $106 |
| Bioventus LLC | 1 | $95 |
| Stryker | 2 | $45 |
| Zimmer Biomet | 1 | $37 |
| Organogenesis Inc. | 1 | $25 |
| Cashflow Solutions, LLC | 1 | $17 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$1,061
- Kerecis Omega3 Marigen$654
- Portfolio$569
- Kerecis Omega3 GraftGuide$429
- RENASYS GO v2 HOME$249
- PICO 7$121
- RENASYS TOUCH$121
- GRAFIX PL$115
- STRAVIX PL$115
- CMF$112
How this compares
Too few primary podiatric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Dublin
- Brock LidenCircleville$453K
- Shital PemaKettering$299K
- Megan OltmannSolon$177K
- Gary MostChesterland$4K
- Thomas CiresiRichmond Heights$4K
- David BaerColumbiana$3K
- Abena AgyepongCincinnati$3K
- Samuel MakanjuolaColumbus$2K
- Matthew NarducciColumbiana$2K
- Joseph ArtersYoungstown$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.